Found 488 matching trials
A Clinical Trial of Adoptive Transfer With Autologous NKT Cells in Metastatic Melanoma Patients
PHASE1Considerable progress in the treatment of metastatic melanoma has been made...
Location
Beijing Cancer Hospital
Study of IFN-α Combined With CAR-T Cell Therapy in Relapsed and Refractory Acute Lymphoblastic Leukemia(R/R-ALL)
PHASE2The purpose of this study is to evaluate the safety and efficacy of IFN-α c...
Location
The First Affiliated Hospital of Soochow University
Clinical Study of Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of Relapsed/Refractory Non-Hodgkin Lymphoma
PHASE1This is a phase I clinical study to evaluate the safety and efficacy of CAR...
Location
Shandong Second Provincial General Hospital
Re-directed T Cells for the Treatment (FAP)-Positive Malignant Pleural Mesothelioma
EARLY_PHASE1MPM patients are not eligible for surgical procedures like decortication or...
Location
University Hospital Zurich, Division of Oncology
Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases
PHASE1The CATARSIS study explores the use of anti-CD19 CAR T-cell therapy as a no...
Location
Fondazione Policlinico Universitario A. Gemelli IRCCS
Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced Cancer
PHASE1This phase I clinical trial evaluates the safety and feasibility of adminis...
Location
UCLA / Jonsson Comprehensive Cancer Center
PRGN-3006 Adoptive Cellular Therapy for CD33-Positive Relapsed or Refractory AML, MRD Positive AML or Higher Risk MDS
PHASE1This is a first-in-human dose escalation/dose expansion study to evaluate t...
Status
Active Not Recruiting
Location
H Lee Moffitt Cancer Center and Research Institute
Treatment of Chemotherapy Refractory Multiple Myeloma by CART-138
PHASE1RATIONALE: Placing a tumor antigen chimeric receptor that has been created ...
Location
Chinese PLA General Hospital
Safety and Efficacy of Loco-regional B7H3 IL-7Ra CAR T Cell in DIPG
PHASE1A Phase 1 clinical trial to evaluate the safety and early efficacy of CAR T...
Location
King Chulalongkorn Memorial Hospital
Treatment of Children CD19+ Leukemia and Non-Hodgkin Lymphoma With CD19-TriCAR-T/SILK Cell Therapy
EARLY_PHASE1This is a single arm, open-label, early phase Ⅰ study, to determine the saf...
Location
Hunan Provincial People's Hospital